Skip to main content
. 2014 Oct 3;12:95. doi: 10.1186/1477-7827-12-95

Table 1.

LH and hCG content (immunoreactivity) of different urinary hMG preparations

Product LH IU/vial (SD) hCG IU/vial (SD) LH/hCG ratio Study
Pergonal 13.49 (3.6) 3.39 (1.7) 3.98 Wolfenson et al. [4]
Humegon 5.77 (1.0) 6.86 (1.8) 0.84 Wolfenson et al. [4]
Menopur 0.29 (5.2) 9.61 (2.3) 0.03 Wolfenson et al. [4]
Menopur 0.48 (1.7) 9.05 (3.3) 0.05 Wolfenson et al. [4]
Menopur 0.39 (3.1) 11.06 (1.8) 0.04 Wolfenson et al. [4]
Menopur 0.85 (0.18) 11.3 (1.0) 0.08 Giudice et al. [6]
Menopur 3 (range 2.7–5.3) 10 (range 9.9–11.2) 0.03 Van de Weijer et al. [5]

hCG human chorionic gonadotropin; IU international units; LH luteinising hormone; hMG human menopausal gonadotropin.

HHS Vulnerability Disclosure